MCTA

+ Watchlist + Portfolio

Charming Medical Limited

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $29.36
52-Week Range: $4.30 – $31.70
Market Cap: $445.55M
P/E (TTM): 419.36
EPS (TTM): 0.07
Dividend Yield: —

Advanced Metrics

Price/Book: 97.20
PEG Ratio: —
Return on Equity: -0.87%
Return on Assets: 0.89%
Gross Margin: 96.36%
Operating Margin: 4.86%
Profit Margin: -0.47%
Current Ratio: 1.89
Debt/Equity: 0.18
Total Debt: $908.02K
Free Cash Flow: $-507.04K
Revenue Growth: -18.90%
Earnings Growth: -93.80%
Enterprise Value: $497.49M

MCTA Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$3.53M	$6.02M	$6.22M	$4.81M
Cost of Revenue	$2.04M	$2.10M	$2.04M	$1.80M
Gross Profit	$1.49M	$3.91M	$4.18M	$3.01M
Selling, General & Admin	$1.66M	$2.35M	$2.32M	$2.68M
Operating Expenses	$1.78M	$2.74M	$2.57M	$2.88M
Operating Income	-$287.50K	$1.17M	$1.62M	$128.87K
EBITDA	-$189.13K	$1.42M	$1.72M	$365.34K
Pretax Income	-$420.47K	$1.00M	$1.44M	$133.47K
Income Tax	-$84.86K	$181.75K	$236.08K	$156.11K
Net Income	-$305.12K	$777.81K	$1.20M	-$22.65K
Diluted EPS	-0.02	0.05	0.07	—
Diluted Shares	16.94M	16.94M	16.94M	—

MCTA Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$1.93M	$2.10M	$816.77K	$4.70M
Receivables	$2.12M	$1.54M	$579.09K	$1.61M
Inventory	$66.33K	$28.15K	$26.80K	$25.62K
Current Assets	$4.12M	$3.67M	$3.37M	$8.17M
Total Assets	$6.38M	$4.88M	$5.36M	$9.87M
Current Liabilities	$7.17M	$5.88M	$4.95M	$4.33M
Total Debt	$1.81M	$961.38K	$1.16M	$908.02K
Total Liabilities	$7.65M	$6.03M	$5.31M	$4.69M
Retained Earnings	-$1.16M	-$1.08M	$119.44K	$96.79K
Shareholders' Equity	-$1.16M	-$1.08M	$49.24K	$5.18M
Working Capital	-$3.05M	-$2.21M	-$1.58M	$3.84M

MCTA Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$2.43M	$295.43K	$425.89K	-$1.22M
Capital Expenditure	-$606.19K	-$210.60K	-$287.53K	-$339.56K
Free Cash Flow	$1.83M	$84.83K	$138.36K	-$1.56M
Depreciation & Amortisation	$211.08K	$391.70K	$263.45K	$216.07K
Investing Cash Flow	-$606.19K	-$210.60K	-$2.23M	-$179.01K
Financing Cash Flow	-$1.43M	$100.14K	$521.30K	$5.29M
Net Change in Cash	$397.33K	$184.98K	-$1.28M	$3.90M

MCTA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q3 2025	Q1 2026
Cash & Equivalents	$816.77K	$1.77M	$4.70M
Receivables	$579.09K	$200.45K	$1.61M
Inventory	$26.80K	$39.98K	$25.62K
Current Assets	$3.37M	$2.93M	$8.17M
Total Assets	$5.36M	$5.45M	$9.87M
Current Liabilities	$4.95M	$4.99M	$4.33M
Total Debt	$1.16M	$573.36K	$908.02K
Total Liabilities	$5.31M	$5.10M	$4.69M
Retained Earnings	$119.44K	$46.46K	$96.79K
Shareholders' Equity	$49.24K	$357.97K	$5.18M
Working Capital	-$1.58M	-$2.06M	$3.84M

Market Snapshot

About

Charming Medical Limited is a China-based medical device company specializing in surgical staplers and other surgical instruments for minimally invasive procedures.